Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 2 |
2013 | 1 |
2014 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma.
Target Oncol. 2012 Sep;7(3):199-210. doi: 10.1007/s11523-012-0227-8. Epub 2012 Sep 12.
Target Oncol. 2012.
PMID: 22968692
Review.
Inhibition of MET receptor tyrosine kinase and its ligand hepatocyte growth factor.
Sadiq AA, Salgia R.
Sadiq AA, et al.
J Thorac Oncol. 2012 Dec;7(16 Suppl 5):S372-4. doi: 10.1097/JTO.0b013e31826df03e.
J Thorac Oncol. 2012.
PMID: 23160322
Free article.
Review.
No abstract available.
Item in Clipboard
Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer.
Kawada I, Hasina R, Arif Q, Mueller J, Smithberger E, Husain AN, Vokes EE, Salgia R.
Kawada I, et al.
Cancer Res. 2014 Feb 1;74(3):884-95. doi: 10.1158/0008-5472.CAN-12-3583. Epub 2013 Dec 4.
Cancer Res. 2014.
PMID: 24305878
Free PMC article.
Item in Clipboard
Cite
Cite